Top Tweets for #cf33
Check out Brent Burns ‘23-24 UD Allure Hockey #CF33 Red-Orange Hurricanes https://t.co/a9BiZELcZP #eBay via @eBay #TBBCrew #TBBReposts
We’ve been granted a patent in #India for our #CF33 oncolytic virotherapy technology, protecting the method of composition and method of use until 2037. This strengthens our global intellectual property, adding to existing patents in the United States and Japan.
Managing Director and CEO Leslie Chong said: “The grant of this India patent is another significant step in expanding global protection for CF33, building on our strong foundation in key markets such as the US and Japan. We remain committed to advancing our oncolytic virotherapy pipeline and delivering next-generation immunotherapies to patients worldwide.”
Read the full $IMU #ASX Announcement here: https://t.co/MrLzIAI4Iq
#Imugene #IMU #ASX #ASXNews #Biotech #OncolyticVirus #CancerResearch #ImmunoOncology #Patent
CEO Leslie Chong joined Money News with Scott Haywood in a national radio interview yesterday to discuss Imugene's announcement that the first patient has been dosed in the Company's trial for bile tract cancer (cholangiocarcinoma) using #CF33 (#VAXINIA).
Click here to listen: https://t.co/phGImVZ8oe
@2GB873 @3AW693 @6PR @NewsTalk4BC #IMU #Immunotherapy #ASX
We've received a Notice of Grant from the Chinese Patent Office for our oncolytic virotherapy #CF33, including #VAXINIA and #CHECKvacc.
This patent, titled "CHIMERIC POXVIRUS COMPOSITION AND USES THEREOF," provides protection for the method of composition and method of use of CF33 until 2037.
CF33, a chimeric vaccinia poxvirus developed from the lab of inventor Professor Yuman Fong, aims to selectively kill #tumour cells and activate the immune system against #cancer cells.
This patent grant in #China, along with earlier grants in #Japan and South Korea, marks a significant milestone for $IMU's efforts in the field of #oncolytic #virotherapy.
Read the full #ASX Announcement here: https://t.co/SFh19KdXGe
💥CASTIEL MISSING #KENFIGHILL, #BRIDGEND, #CF33, #WALES 💥
Friday 29th March 2024
💥Microchipped, Neutered and wearing a bow tie collar
💥💥POSSIBLY BEEN CLIPPED BY A CAR ON PWLLYGATH STREET. PLEASE CHECK GARDENS AND RING NUMBER ON POSTER WITH ANY INFORMATION/SIGHTINGS
Imugene was on the @SevenNetwork last night showcasing the potential of our #CF33 #oncolytic virus to target and fight various #cancers and #tumour types.
A big thank you to the patients involved, Professor Yuman Fong for his scientific leadership, and @amberlaidler7 for covering this story.
To learn more about $IMU's CF33, visit our website at https://t.co/34y2tbKOok
Following recent successes, @TeamImugene has advanced its Phase 1 clinical study with the first Cohort 5 patients now receiving doses of the company’s novel potentially #cancer-killing drug.
$IMU #BULLSNBEARSWA #ASX @westaustralian #Vaxinia #CF33
https://t.co/YtGuUM7pBc
‼️BEAR AND MARLEY BOTH MISSING #KENFIGHILL, #BRIDGEND, #CF33 area #WALES
Wednesday 27th December 2023
Both microchipped and wearing Blue collars
‼️PLEASE RING NUMBERS WITH ANY INFORMATION/SIGHTINGS
ASX News:
Next cohort reached in intravenous arms of monotherapy and combination study for cancer-killing virus CF33-hNIS (VAXINIA)
More at https://t.co/TkJeRiT4Ae
$IMU $IMU.ax #CF33 #OncolyticVirus #VAXINIA
We invite you to visit our investor section to read our latest analyst coverage from ROTH Capital Partners.
Their 12-month price target is AUD 0.71.
• https://t.co/LzdcERpEXR
#CF33 #onCARlytics #OncolyticVirus $IMU $IMU.ax
Leslie emphasises "this is a perfect time to introduce an immune checkpoint inhibitor such as pembrolizumab.”
$IMU $IMU.ax #VAXINIA #CF33 #OncolyticVirus
"The results presented at SITC further build our confidence as to the potential benefit to patients from these technologies and provide an excellent platform for further clinical development." - Leslie Chong, CEO $IMU @sitcancer $IMU.ax #onCARlytics #CF33
“The VAXINIA trial continues to progress on schedule and we’re very excited to see the results it can deliver for these patients dealing with significant tumour growth.” - Leslie Chong, CEO $IMU
More: https://t.co/TLCgPhnSLk
#EndCancer #VAXINIA #CF33
Our onCARlytics #CF33 oncolytic virus technology will be featured in three abstracts at the renowned Annual Meeting for the Society for Immunotherapy of Cancer (SITC), to be held in Boston, USA on 8-12 November 2022.
More via: https://t.co/xs8oXauyhl
$IMU #Immunotherapy #Biotech
Our new Executive Director of Clinical Science at @TeamImugene Dr Sharon Yavrom is speaking on #CF33 OV platform in December. #groundbreaking #standingroomonly #Thisistheway
NCI researchers are developing an #immunotherapy that involves injecting protein bits from cytomegalovirus (CMV) into tumors. In mice, the treatment shrank tumors and kept them from returning. https://t.co/2dQA9lwu3P @nciresearchctr
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.8M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.8M followers
Taylor Swift
@taylorswift13
81.6M followers
Lady Gaga
@ladygaga
73.2M followers
Virat Kohli
@imvkohli
70.1M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
62.8M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.9M followers
X
@x
60.8M followers